Research Collection

Mitochondrial Peptides

Mitochondria-targeted research compounds studied for membrane stabilization, biogenesis signaling, and metabolic regulation at the organelle level.

Mitochondrial Peptides are research compounds studied for their direct interaction with mitochondrial architecture and signaling, encompassing cardiolipin-binding membrane stabilizers, mitochondrial-derived signaling peptides, and metabolic cofactors that support electron transport chain function. This category features SS-31, MOTS-c, and NAD+, each investigated for distinct mechanism classes, and is offered strictly for laboratory research use.

Reviewed by the VivePeptides Research DeskLast reviewed

Research Catalog

Compounds in this collection

Research Overview

Mitochondria-Targeted Peptides: A Distinct Research Category

This collection brings together peptides for mitochondria and related metabolic cofactors that act directly on mitochondrial structure, signaling, or cofactor pathways, distinguishing it from broader bioenergetic or aging-focused research lines. Mitochondrial dysfunction is implicated in a wide range of cellular stress models, making mitochondria-targeted peptides and cofactor compounds an active area of preclinical investigation. Researchers typically select among these mechanism classes based on the mitochondrial process under investigation rather than a general metabolic outcome.

Three mechanism classes are represented here. SS-31 is studied as a cardiolipin-binding peptide that localizes to the inner mitochondrial membrane. MOTS-c is a mitochondrial-derived peptide investigated for retrograde signaling between mitochondria and the nucleus.

NAD+ is examined as a metabolic cofactor central to electron transport chain function and sirtuin activity. VivePeptides sources each compound with third-party purity documentation and provides certificates of analysis, positioning the catalog as a reference point for researchers comparing mitochondria-targeted mechanism classes side by side.

Three Distinct Mechanism Classes

SS-31, MOTS-c, and NAD+ engage mitochondria through different points of entry: membrane binding, retrograde signaling, and cofactor metabolism. Researchers select among them based on which pathway the study model requires.

Purity and Documentation Standards

Each compound listed here ships with third-party testing documentation and a certificate of analysis. Verifying identity and purity before use is standard practice in mitochondrial research protocols.

Handling and Reconstitution Considerations

Membrane-binding peptides, signaling peptides, and metabolic cofactors have different solubility and stability profiles. Reconstitution and storage protocols should be matched to the specific compound class, not treated uniformly across the collection.

Compound Comparison

How these compounds compare

CompoundMechanism ClassResearch FocusDistinguishing Feature
SS-31Cardiolipin-binding membrane peptideInner membrane structure, cristae integrityLocalizes to inner mitochondrial membrane
MOTS-cMitochondrial-derived signaling peptideRetrograde nuclear signaling, AMPK pathwayEncoded within mitochondrial DNA
NAD+Metabolic cofactorElectron transport chain, sirtuin/PARP substrateRequired cosubstrate for redox reactions

Mechanism & Research Context

Mechanism Classes and Study Design Considerations

What distinguishes these mechanism classes is the specific mitochondrial structure or pathway each compound engages, rather than a shared downstream phenotype. SS-31's cardiolipin affinity has been examined in models of inner membrane cristae disruption and cytochrome c mishandling. MOTS-c's translocation behavior under metabolic stress has been studied in the context of AMPK pathway activity and nuclear gene expression changes.

NAD+ depletion and repletion have been examined across models of sirtuin and PARP enzyme activity, both of which depend on NAD+ as a substrate. Researchers selecting between these compounds generally consider whether the model calls for direct membrane interaction, retrograde signaling, or cofactor-level intervention. Study design also requires attention to solubility, reconstitution protocol, and storage stability, since membrane-binding peptides, signaling peptides, and small-molecule cofactors behave differently in solution.

Documentation of compound identity and purity is a baseline requirement across all three mechanism classes in controlled research settings.

Research FAQ

Frequently asked questions

What makes a peptide mitochondria targeted rather than just metabolically active?

A mitochondria-targeted compound engages a specific mitochondrial structure or pathway directly, such as the inner membrane, mitochondrial DNA-derived signaling, or a metabolic cofactor pathway, rather than producing a general downstream metabolic effect. SS-31 exemplifies this through direct cardiolipin binding, MOTS-c through mitochondrial-to-nuclear signaling, and NAD+ through its role as a required cofactor in redox and sirtuin reactions. This mechanistic specificity is what defines the category in preclinical research literature.

How does SS-31 differ from MOTS-c in research applications?

SS-31 and MOTS-c are studied through different mechanism classes: SS-31 is examined for its direct binding to cardiolipin on the inner mitochondrial membrane, while MOTS-c is investigated as a mitochondrial-derived peptide involved in retrograde signaling to the nucleus. Because they act on different structures, they are typically studied in different experimental contexts rather than as interchangeable compounds. Researchers select between them based on whether the model requires membrane-level or signaling-level investigation.

Why is NAD+ included in a mitochondrial peptides collection?

NAD+ is included because it functions as an essential metabolic cofactor for mitochondrial redox reactions and is a required substrate for sirtuin and PARP enzymes involved in mitochondrial regulation. While NAD+ is not itself a peptide, it is grouped with SS-31 and MOTS-c here because all three compounds are studied for their direct role in mitochondrial-level processes. This grouping reflects mechanism class rather than molecular structure.

What research models have examined cardiolipin-binding peptides like SS-31?

Cardiolipin-binding peptides such as SS-31 have been examined in preclinical models of inner mitochondrial membrane disruption, including cristae architecture and cytochrome c interactions. Research in this area has focused on how stabilizing cardiolipin's structural role affects downstream mitochondrial membrane function. These studies typically use isolated mitochondria or cell culture models rather than whole-organism designs. Findings in this literature are preliminary and specific to the experimental conditions studied.

How should researchers store and reconstitute mitochondrial peptides purchased from VivePeptides?

Storage and reconstitution protocols vary by compound class, so researchers should follow the certificate of analysis and product-specific documentation provided with each order. Membrane-binding peptides, signaling peptides, and metabolic cofactors have distinct solubility and stability characteristics that affect appropriate handling. VivePeptides provides documentation with each compound to support proper laboratory protocol. All products are intended strictly for research use, not for human or animal administration.

Is MOTS-c considered a mitochondrial-derived peptide, and what does that mean for research use?

Yes, MOTS-c is classified as a mitochondrial-derived peptide because it is encoded within mitochondrial DNA rather than the nuclear genome. This origin is central to its research relevance, as MOTS-c has been studied for its role in communicating mitochondrial status to the nucleus under metabolic stress conditions. Research in this area typically examines AMPK pathway activity and downstream gene expression changes. As with all compounds on this page, MOTS-c is supplied for laboratory research use only.

All products are sold strictly for laboratory and scientific research use only. Not for human or animal consumption, diagnostic, or therapeutic use. Nothing on this page constitutes medical advice or a health claim.